Intestinal Low Dose Radiotherapy-1Gy
Sponsors
Chuangzhen Chen
Conditions
Borderline Resectable CarcinomaChemotherapyEsophageal Squamous Cell Carcinoma (ESCC)Immune Checkpoint BlockadeImmune Checkpoint InhibitorMetastatic Malignant Solid NeoplasmRadiotherapyResistance to Immunotherapy
Phase 2
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors
CompletedNCT06076135
Start: 2023-12-26End: 2026-05-10Updated: 2026-07-30
Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma
RecruitingNCT07339488
Start: 2025-12-05End: 2028-11-01Target: 43Updated: 2026-06-18